Third Rock is celebrating our First Decade! And we have joined Twitter - we hope you will follow along. Learn more about the core values that drive us bit.ly/2zKNnna
Third Rock Ventures
374 posts
Third Rock Ventures
@ThirdRockV
- Congratulations to TRV partner Abbie Celniker for being awarded @MassBio’s Henri A. Termeer Innovative Leadership Award! We appreciate all you do to advance innovation in our industry. bit.ly/326SQQJ
- We just launched Fund VI with $1.1 billion and are very excited to go create more companies! thirdrockventures.com/uploads/press-…
- We just launched Fund V with $770M are very excited to go create more companies! bit.ly/2KBxm7v
- Congratulations to Third Rock co-founder and partner Mark Levin for being honored with @Xconomy’s Lifetime Achievement Award! Thank you for all you’ve done for patients throughout your career. bit.ly/2Yy5uEv
- A huge congratulations to @bluebirdbio on receiving EU approval of Zynteglo - the first gene therapy approved for transfusion-dependent β-thalassemia. What a great day for patients, gene therapy, and all those hard-working bluebirds!!
- We are thrilled that Steve Kafka has joined as a venture partner. Welcome Steve!
- Welcome to our newest portfolio company: Maze Therapeutics! Maze’s approach will leverage genetic modifiers – a natural protection against disease – to create medicines for severe diseases. Learn more here: mazetx.com #trvportco
- Mark Levin, our co-founder and partner, received the @Xconomy Lifetime Achievement Award last night, with an inspiring message about the importance of bringing humility and empathy to all we do. Congratulations Mark!
- Today we are excited to share three new venture partners are joining the TRV team: Dr. Andrea van Elsas, Dr. David Kaufman, and Dr. Lorence Kim. Welcome to all!
- We are thrilled to announce that Dodzie Sogah, Ph.D., has been promoted to Venture Partner. Dodzie has made a huge impact during his time here at Third Rock and we look forward to his future contributions. Join us in congratulating him on his new role!
- Welcome to Rheos Medicines, launched today to harness immune cells to bring precision medicines to immune-mediated diseases. Tune in here bit.ly/2HX0cuh to learn more! @Rheosrx #trvportco
- Alexis Borisy giving a keynote at @Xconomy #xconxcelerate during @BiotechWkBoston and discussing the metric that matters most: getting medicines to patients.
